Semaglutide and heavy periods: what's actually happening

Why your period might feel different when you start losing weight on semaglutide

The decision many women face on semaglutide is whether a change in their period is something to monitor, something to act on, or simply to expect as their body adjusts. That framing matters, because the mechanism behind most reported cycle changes is not specific to semaglutide at all.

Adipose tissue, the fat stored around the body, is hormonally active. It produces and stores oestrogen. When weight falls relatively quickly, which it can on semaglutide, oestrogen levels in the blood can fluctuate. The hypothalamus and pituitary gland, which release the hormones that trigger ovulation and regulate cycle timing, are sensitive to those fluctuations. The result can be periods that arrive earlier or later than expected, that produce more or less blood than usual, or that feel physically different from your baseline.

This is the same mechanism that causes cycle disruption after rapid weight loss from any cause, including dietary restriction, bariatric surgery or intensive exercise. Semaglutide may simply make this effect more pronounced by producing a faster calorie deficit than many people achieve through lifestyle changes alone. Research published in the STEP 1 trial in the New England Journal of Medicine, which assessed semaglutide 2.4mg over 68 weeks, documented significant mean body weight reduction; the hormonal consequences of that degree of loss are a recognised physiological response.

Women with polycystic ovary syndrome (PCOS) represent a particular group here. PCOS is associated with insulin resistance and elevated androgens, and weight loss often improves cycle regularity in these patients. Some women who had very light or absent periods due to PCOS find their cycles restart or normalise, which can initially feel like a heavier or more frequent bleed compared to their recent baseline. For a broader look at how semaglutide interacts with the menstrual cycle across different situations, our guide on semaglutide and your period brings together the key considerations in one place.

Distinguishing a normal hormonal adjustment from something that needs medical attention

Not every change in bleeding is benign, and semaglutide does not protect against underlying gynaecological conditions. The practical question is: which changes are likely to settle, and which need investigation?

Changes that are commonly reported as transient during the first two to four months of treatment include slightly heavier flow, one or two cycles arriving earlier or later than expected, and minor cramping differences. These tend to ease as the rate of weight loss moderates and oestrogen levels find a new equilibrium.

Changes that warrant a prompt GP or gynaecological review include: soaking through a pad or tampon every hour for several consecutive hours, passing clots larger than a 50p coin, bleeding between periods rather than at them, and any bleeding that continues for longer than seven days. These patterns, whether or not you are on semaglutide, deserve investigation to rule out causes that have nothing to do with weight loss, such as fibroids, endometrial changes or thyroid dysfunction.

The NHS semaglutide medicines page lists the known side effects of the medicine; heavy menstrual bleeding is not among them, which is useful context. It does not mean cycle changes are impossible, but it means the driver is more likely systemic than pharmacological. If you are uncertain, the safest route is always a conversation with your GP.

Oral contraceptives, absorption and a specific consideration for tirzepatide users

Semaglutide slows gastric emptying, which is central to how it reduces appetite. For most oral medicines, this effect is small enough to be clinically insignificant. The current prescribing guidance does not require women taking semaglutide to switch from oral contraceptives or add additional barrier methods. That is worth knowing, because some people read about GLP-1 medicines and assume all of them carry the same contraceptive absorption caveat.

The caveat applies specifically to tirzepatide (Mounjaro), where UK guidance advises adding a non-oral method for the first four weeks of treatment and for four weeks after each dose increase. If you are exploring your options and want to compare the two medicines in more detail, our Wegovy overview covers the distinctions clearly.

Regardless of which medicine you are taking, effective contraception while on GLP-1 treatment is important. These medicines are not recommended during pregnancy, and any woman of childbearing age on semaglutide should discuss contraception with her prescriber. Details of how Wegovy interacts with the menstrual cycle more broadly are explored in our piece on periods and Wegovy.

What to discuss with a prescriber if bleeding concerns you

If you are on semaglutide and your periods have become heavier, the most productive conversation with a clinician covers a few specific points: when the change started relative to your dose, how heavy the bleeding is in practical terms (how often you are changing products, whether it is affecting daily life), whether you have any associated pain, and your gynaecological history, including previous diagnoses of PCOS, fibroids or endometriosis.

Bring this information to your GP rather than adjusting your semaglutide yourself. Stopping or pausing treatment without clinical guidance is not the answer to a gynaecological question, and abrupt changes to a titration schedule should always involve the prescriber who oversees your weight management. You can explore whether semaglutide could affect cycle timing more broadly on our page covering whether semaglutide can make your period late, and if you have had no period at all since starting treatment, our page on missing a period on Wegovy addresses that separately.

If you are still weighing up whether semaglutide is right for you and want to understand the full picture before starting, our prescribers are available seven days a week. You can review the treatment options and check your eligibility through a free consultation, where questions like these, including everyday ones such as whether foods like bananas are suitable while taking Wegovy, can be discussed properly before any prescription is written.